Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s42399-020-00448-0 http://scihub22266oqcxt.onion/10.1007/s42399-020-00448-0 32838187!7426163!32838187     free     free     free       SN+Compr+Clin+Med 2020 ; 2 (9): 1436-1443 Nephropedia Template TP {{tp|p=32838187|t=2020. Protease Inhibitor Use in COVID-19 |pdf=|usr=}}{{32838187}} gab.com Text Protease Inhibitor Use in COVID-19 JO: SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=32838187 #FOAvip The outbreak of a large plaque, novel coronavirus pneumonia (NCP), which also named Coronavirus Disease 2019 (COVID-19) by the WHO, has detrimentally affected the livelihood and health of people in China. During the spread of COVID-19, colleagues who have been working at the frontline have had to face many new challenges in the treatment and prevention of NCP. Therefore, we have provided suggestions for the diagnosis, treatment, and prevention of the novel coronavirus pneumonia in the current epidemic situation based on the latest reports and the experience of doctors treating COVID-19 in our hospital. We recommend lopinavir/ritonavir as the effective drugs for antiviral treatment according to our experience in administering lopinavir/ritonavir to COVID-19 patients and the successful cases of these drugs in treating MERS and SARS, but need more clinical data to prove their efficacy in treating COVID-19. Twit Text FOAVip Protease Inhibitor Use in COVID-19 ????SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=32838187 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32838187 #FOAvip English Wikipedia <ref>{{Cite pmid|32838187}}</ref> Protease Inhibitor Use in COVID-19 #MMPMID32838187 Song Y; Peng W; Tang D; Dai Y SN Compr Clin Med 2020[]; 2 (9): 1436-1443 PMID32838187show ga The outbreak of a large plaque, novel coronavirus pneumonia (NCP), which also named Coronavirus Disease 2019 (COVID-19) by the WHO, has detrimentally affected the livelihood and health of people in China. During the spread of COVID-19, colleagues who have been working at the frontline have had to face many new challenges in the treatment and prevention of NCP. Therefore, we have provided suggestions for the diagnosis, treatment, and prevention of the novel coronavirus pneumonia in the current epidemic situation based on the latest reports and the experience of doctors treating COVID-19 in our hospital. We recommend lopinavir/ritonavir as the effective drugs for antiviral treatment according to our experience in administering lopinavir/ritonavir to COVID-19 patients and the successful cases of these drugs in treating MERS and SARS, but need more clinical data to prove their efficacy in treating COVID-19. äProtease Inhibitor Use in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing